Pamela W. Anderson - Concepedia

Author

Pamela W. Anderson

Eli Lilly (United States)

Also Known As

P W Anderson, P.W Anderson, P.W. Anderson, PAMELA W. ANDERSON, Pamela Anderson, Pamela W Anderson, Pamela W. Anderson

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of Southern California Los Angeles Medical Center University of California San Diego LAC+USC Medical Center

About

Pamela W. Anderson is an author at Eli Lilly (United States) specializing in medicine, cardiovascular disease, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.1K
2	Diabetes	4	4	269
3	Endocrinology	4	4	542
4	Public Health	3	3	211
5	Cell Biology	1	1	116

Pamela W. Anderson

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women Elizabeth Barrett‐Connor, Deborah Grady, Andreas Sashegyi, JAMA	2002	574
The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled Trial1 Brian W. Walsh, Sofia Paul, Robert A. Wild, The Journal of Clinical Endocrinology & Metabolism GynecologyMenopausal Hormone TherapyPharmacotherapyMetabolic SyndromeHealthy Postmenopausal Women	2000	331
The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes Katherine R. Tuttle, George L. Bakris, Robert D. Toto, Diabetes Care	2005	301
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study Joan T. Merrill, Ronald van Vollenhoven, Jill P. Buyon, Annals of the Rheumatic Diseases	2015	218
Design and methods of the Raloxifene Use for The Heart (RUTH) study Lori Mosca, Elizabeth Barrett‐Connor, Nanette K. Wenger, The American Journal of Cardiology Heart FailureRaloxifene UseCardiovascular DiseaseMedicinePharmacotherapy	2001	166
Angiotensin II causes mesangial cell hypertrophy. Pamela W. Anderson, Y S, Willa A. Hsueh Hypertension	1993	126
Human decidua is a major source of renin. Kathy Shaw, Y S, Siri L. Kjos, Journal of Clinical Investigation Organ PhysiologyGynecologyFemale Reproductive FunctionReproductive BiologyEmbryology	1989	121
Insulin and angiotensin II are additive in stimulating TGF-β1 and matrix mRNAs in mesangial cells Pamela W. Anderson, Xiaoying Zhang, Tian Jin, Kidney International Developmental BiologyAngiogenesisMolecular PhysiologySignal TransductionAngiotensin Ii	1996	116
Kidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease Katherine R. Tuttle, Janet B. McGill, Douglas J. Haney, Clinical Journal of the American Society of Nephrology	2007	95
Identification of renal cathepsin B as a human prorenin-processing enzyme P.H. Wang, Y.S. Do, Laura J. Macaulay, Journal of Biological Chemistry	1991	87

Page 1